Keywords: Polymers; Ocular drug delivery; Nanoparticles; Microparticles; Gels; Ocular bioavailability; ABC; ATP-binding cassette superfamily; ANDA; Abbreviated new drug application; AUC; Area-under-the-curve; BSA; Bovine serum albumin; DDS; Drug delivery system; EP
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AAS; Atomic Absorption Spectrophotometry; bw; body weight; DDA; Direct Automatic Analyzer; dw; dry weight; EFSA; European Food Safety Authority; EU; European Union; EC; European Commission; FAO; Food and Agriculture Organisation of the United Nations; Hg;
The essential oil of Algerian Ammodaucus leucotrichus Coss. & Dur. and its effect on the cholinesterase and monoamine oxidase activities
Keywords: A. leucotrichus C. & D.; Essential oil; Anti-cholinesterase activity; Anti-monoamine oxidase; AD; Alzheimer's disease; AChE; Acetylcholinesterase; ATCh; Acetylthiocholine; BuchE; Butyrylcholinesterase; ChE; Cholinesterase; DMSO; Diméthylsulfoxyde; DTNB;
Implementing the additional strength biowaiver for generics: EMA recommended approaches and challenges for a US-FDA submission
Keywords: Strength; Biowaiver; EMA; US-FDA;
Nanopharmaceuticals for wound healing - Lost in translation?
Keywords: Nanomaterials; Biomaterials; Advanced wound healing therapies; Current regulatory perspective; ASTM; American Society for Testing and Materials; CQA; critical quality attributes; ECM; extracellular matrix; EGF; epidermal growth factor; EMA; European medic
Surface modified nano-lipid drug conjugates of positive allosteric modulators of M1 muscarinic acetylcholine receptor for the treatment of Alzheimer's disease
Keywords: US-FDA; United States Food and Drugs Administration; AD; Alzheimer's disease; ACh; acetylcholine; PAM; positive allosteric modulator; mAChR; muscarinic acetylcholine receptor; AChE; acetylcholine esterase; LDC; lipid drug conjugate; NP; nanoparticle; GP
Qualitative and quantitative assessment of the presence of ciguatoxin, P-CTX-1B, in Spanish Mackerel (Scomberomorus commerson) from waters in New South Wales (Australia)
Keywords: CFP; Ciguatera Fish Poisoning; CTX; Ciguatoxin; LC-MS; Liquid chromatography mass spectrometry; MTX; Maitotoxin; NMR; Nuclear magnetic resonance; NSW; New South Wales; NT; Northern Territory; P-CTX-1B; Pacific Ciguatoxin 1B; QLD; Queensland; RLB; Radio
Nanomedicines in the future of pediatric therapy
Keywords: ACTs; artemisinin combined therapies; ALN; alendronate; ANMAT; Administración Nacional de Medicamentos, Alimentos y TecnologÃa Médica; ARV; antiretrovirals; AS; antisense; AUC; area-under-the-curve; BMS; burning mouth syndrome; CD; cytosine deaminase;
Reversal of multidrug resistance by the inhibition of ATP-binding cassette pumps employing “Generally Recognized As Safe” (GRAS) nanopharmaceuticals: A review
Keywords: ABC; ATP-binding cassette superfamily; ART; Antiretroviral therapy; AUC; Area-Under-the-Curve; BCS; Biopharmaceutic Classification System; BCRP; Breast cancer resistance protein; CD; Cyclodextrins; CFR; Code of Federal Regulations; CMC; Critical Micellar
Real-time determination of critical quality attributes using near-infrared spectroscopy: A contribution for Process Analytical Technology (PAT)
Keywords: SOPs; Standard Operating Procedures; PAT; Process Analytical Technology; US-FDA; United States Food and Drug Administration; NIRS; near infrared spectroscopy; HPLC; high-performance liquid chromatography; ISO; International Organization for Standardizatio